| Q38946174 | A single gene connects stiffness in glaucoma and the vascular system |
| Q90392507 | Aldosterone, inactive matrix gla-protein, and large artery stiffness in hypertension |
| Q36155038 | Arteriosclerotic Calcification: A Serpi(n)ginous Path to Cardiovascular Health? |
| Q64276364 | Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review |
| Q38889423 | Bone loss and vascular calcification: A bi-directional interplay? |
| Q64062422 | Central Hemodynamics in Relation to Circulating Desphospho-Uncarboxylated Matrix Gla Protein: A Population Study |
| Q88774402 | Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness |
| Q26771243 | Concepts and Controversies in Evaluating Vitamin K Status in Population-Based Studies |
| Q37607403 | Crosstalk between Vitamins A, B12, D, K, C, and E Status and Arterial Stiffness. |
| Q47676686 | Desphospho-uncarboxylated matrix Gla protein is a novel circulating biomarker predicting deterioration of renal function in the general population. |
| Q47159417 | Dietary reference values for vitamin K |
| Q52359177 | Epidemiological and histological findings implicate matrix Gla protein in diastolic left ventricular dysfunction. |
| Q101121184 | Generation of a Matrix Gla (Mgp) floxed mouse, followed by conditional knockout, uncovers a new Mgp function in the eye |
| Q51084400 | Inactive Matrix Gla-Protein and Arterial Stiffness in Type 2 Diabetes Mellitus. |
| Q57286573 | Inactive matrix Gla protein is a novel circulating biomarker predicting retinal arteriolar narrowing in humans |
| Q93167842 | Matrix Gla protein maintains normal and malignant hematopoietic progenitor cells by interacting with bone morphogenetic protein-4 |
| Q50219641 | Mechanisms and Subclinical Consequences of Aortic Stiffness |
| Q54996708 | Menaquinone Content of Cheese. |
| Q91718019 | Plasma dephosphorylated-uncarboxylated Matrix Gla-Protein (dp-ucMGP): reference intervals in Caucasian adults and diabetic kidney disease biomarker potential |
| Q38651214 | Public health relevance of drug-nutrition interactions. |
| Q90065574 | Renal Resistive Index Is Associated With Inactive Matrix Gla (γ-Carboxyglutamate) Protein in an Adult Population-Based Study |
| Q51517388 | Renal tissue oxygenation in children with chronic kidney disease due to vesicoureteral reflux. |
| Q37662635 | Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms |
| Q41625344 | The Role of Vitamin K Status in Cardiovascular Health: Evidence from Observational and Clinical Studies |
| Q37262329 | The Role of Vitamin K in Chronic Aging Diseases: Inflammation, Cardiovascular Disease, and Osteoarthritis |
| Q38609846 | US Pharmacopeial Convention safety evaluation of menaquinone-7, a form of vitamin K. |
| Q89388766 | Undercarboxylated Osteocalcin: Experimental and Human Evidence for a Role in Glucose Homeostasis and Muscle Regulation of Insulin Sensitivity |
| Q57293935 | Uromodulin and Nephron Mass |
| Q94547437 | Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein |
| Q36645022 | Vitamin K Dependent Protection of Renal Function in Multi-ethnic Population Studies |
| Q90725004 | Vitamin K Status, Warfarin Use, and Arterial Stiffness in Heart Failure |
| Q92875359 | Vitamin K as a Powerful Micronutrient in Aging and Age-Related Diseases: Pros and Cons from Clinical Studies |
| Q90621476 | Vitamin K, Vascular Calcification, and Chronic Kidney Disease: Current Evidence and Unanswered Questions |
| Q90046444 | Vitamin K-Dependent Matrix Gla Protein as Multifaceted Protector of Vascular and Tissue Integrity |